UOC
HALO icon

UBS O'Connor’s Halozyme HALO Stock Holding History

UBS O'Connor’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,683
Closed -$1.41M – 496
2024
Q3 		$1.41M Sell
24,683
-9,000
-27% -$516K 0.03% 233
2024
Q2 		$1.76M Sell
33,683
-26,000
-44% -$1.14M 0.05% 210
2024
Q1 		$2.43M Buy
59,683
+32,000
+116% +$1.2M 0.07% 147
2023
Q4 		$1.02M Sell
27,683
-40,860
-60% -$1.54M 0.03% 266
2023
Q3 		$2.62M Sell
68,543
-10,000
-13% -$410K 0.05% 192
2023
Q2 		$2.83M Buy
78,543
+8,623
+12% +$294K 0.06% 204
2023
Q1 		$2.67M Buy
69,920
+12,583
+22% +$590K 0.06% 226
2022
Q4 		$3.26M Sell
57,337
-26,600
-32% -$1.36M 0.06% 298
2022
Q3 		$3.32M Sell
83,937
-4,000
-5% -$177K 0.04% 417
2022
Q2 		$3.87M Buy
87,937
+12,937
+17% +$560K 0.04% 414
2022
Q1 		$2.99M Buy
+75,000
New +$2.67M 0.03% 432

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS O'Connor's HALO Position: Q4 2024 in Review

UBS O'Connor sold out of Halozyme (HALO) in Q4 2024, closing a stake of 24,683 shares — an estimated $1.41M sold.

UBS O'Connor first reported a position in HALO in Q1 2022 and held it in 11 quarters. The position peaked at $3.87M in Q2 2022. 509 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • UBS O'Connor reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • UBS O'Connor sold 24,683 Halozyme shares in Q4 2024, an estimated $1.41M.
  • UBS O'Connor first reported a position in Halozyme in Q1 2022 and held it in 11 quarters.
  • UBS O'Connor's Halozyme position peaked at $3.87M in Q2 2022.
  • 509 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.